Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE 250

1,260.00p
   
  • Change Today:
    -44.00p
  • 52 Week High: 1,634.00
  • 52 Week Low: 820.00
  • Currency: UK Pounds
  • Shares Issued: 86.13m
  • Volume: 99,083
  • Market Cap: 1,085.19m
  • RiskGrade: 125
  • Beta: 0.73
Select chart: 1 week
 

Current

1 week

Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-21 161.85 23.94 29.41p 42.8 n/a n/a n/a 0.0%
31-Dec-22 143.82 18.71 20.05p 62.8 n/a -32% n/a 0.0%

Copyright © 2021 FactSet Research Systems Inc. All rights reserved.

Trends & Recommendations

  Current 1 week ago 1 month ago 3 months ago 6 months ago 1 year ago
Revenue (m)
31-Dec-2021 162 162 n/a n/a n/a n/a
31-Dec-2022 144 144 n/a n/a n/a n/a
 
Earnings
31-Dec-2021 29.41p 29.41p n/a n/a n/a n/a
31-Dec-2022 20.05p 20.05p n/a n/a n/a n/a
 
Dividend
31-Dec-2021 n/a n/a n/a n/a n/a n/a
31-Dec-2022 n/a n/a n/a n/a n/a n/a
 
Recommendations
Strong Buy 4 4 0 0 0 0
Buy 0 0 0 0 0 0
Neutral 1 1 0 0 0 0
Sell 0 0 0 0 0 0
Strong Sell 0 0 0 0 0 0
No. of Brokers 5 5 0 0 0 0
 
Average Rec 9.00 9.00 n/a n/a n/a n/a

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Broker estimates sourced from FactSet Estimates +44 (0) 20 3009 7000. FactSet Estimates calculate consensus using only those estimates changed or actively validated within the last 75 days.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

OXB Market Data

Currency UK Pounds
Share Price 1,260.00p
Change Today -44.00p
% Change -3.37 %
52 Week High 1,634.00
52 Week Low 820.00
Volume 99,083
Shares Issued 86.13m
Market Cap 1,085.19m
Beta 0.73
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
72.73% below the market average72.73% below the market average72.73% below the market average72.73% below the market average72.73% below the market average
64% below the sector average64% below the sector average64% below the sector average64% below the sector average64% below the sector average
Price Trend
83.57% above the market average83.57% above the market average83.57% above the market average83.57% above the market average83.57% above the market average
70.00% above the sector average70.00% above the sector average70.00% above the sector average70.00% above the sector average70.00% above the sector average
Income Not Available
Growth
49.93% above the market average49.93% above the market average49.93% above the market average49.93% above the market average49.93% above the market average
23.53% above the sector average23.53% above the sector average23.53% above the sector average23.53% above the sector average23.53% above the sector average

What The Brokers Say

Strong Buy 4
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 5
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for 03-Dec-2021

Time Volume / Share Price
16:35 20,149 @ 1,260.00p
16:29 13 @ 1,266.00p
16:29 75 @ 1,266.00p
16:29 1 @ 1,266.00p
16:29 24 @ 1,266.00p

OXB Key Personnel

CEO John Dawson
CFO Stuart Paynter

Top of Page